APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimicrobial Peptides

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Selected research

Market Structure

Global Antimicrobial Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026193 pages

Choose your research edition.

Industry ResearchAntimicrobial Peptides Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimicrobial Peptides Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Antimicrobial Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimicrobial Peptides Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimicrobial Peptides Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

By region, North America had the highest share of sales, at about 35%.

Read the full market overview

This report provides an overview of the global Antimicrobial Peptides market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antimicrobial Peptides and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antimicrobial Peptides sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antimicrobial Peptides market size, projected growth trends, production technologies, key applications, and end-use industries.

Antimicrobial Peptides Segment by Company

AnaSpec

AMP Biotech

Phoenix Biotech

Novabiotics

Chinese Peptide

Ontores

GenScript

Hycult Biotech

Sunsmile

Ruixing Biotechnology

Zhongnong Yingtai Biotechnology

Glam Technology

ProteLight Pharmaceutical & Biotechnology

Antimicrobial Peptides Segment by Type

Plant Antimicrobial Peptides

Microbial Antimicrobial Peptides

Animal Antimicrobial Peptides

Antimicrobial Peptides Segment by Application

Pharmaceuticals

Feed Additives

Others

Antimicrobial Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimicrobial Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimicrobial Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimicrobial Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antimicrobial Peptides market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antimicrobial Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antimicrobial Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antimicrobial Peptides Industry Trends Table 2. Antimicrobial Peptides Industry Drivers Table 3. Antimicrobial Peptides Industry Opportunities and Challenges Table 4. Antimicrobial Peptides Industry Restraints Table 5. Global Antimicrobial Peptides Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antimicrobial Peptides Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antimicrobial Peptides Sales by Manufacturers (Mg) & (2021-2026) Table 8. Global Antimicrobial Peptides Sales Market Share by Manufacturers Table 9. Global Antimicrobial Peptides Average Sales Price (US$/Mg) of Manufacturers (2021-2026) Table 10. Global Antimicrobial Peptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antimicrobial Peptides Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antimicrobial Peptides Manufacturers, Product Type & Application Table 13. Global Antimicrobial Peptides Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antimicrobial Peptides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plant Antimicrobial Peptides Table 17. Major Manufacturers of Microbial Antimicrobial Peptides Table 18. Major Manufacturers of Animal Antimicrobial Peptides Table 19. Global Antimicrobial Peptides Sales by Type 2021 VS 2025 VS 2032 (Mg) Table 20. Global Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 21. Global Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 22. Global Antimicrobial Peptides Sales Market Share by Type (2021-2026) Table 23. Global Antimicrobial Peptides Sales Market Share by Type (2027-2032) Table 24. Global Antimicrobial Peptides Revenue by Type 2021 VS 2025 VS 2032 (Mg) Table 25. Global Antimicrobial Peptides Revenue by Type (2021-2026) & (Mg) Table 26. Global Antimicrobial Peptides Revenue by Type (2027-2032) & (Mg) Table 27. Global Antimicrobial Peptides Revenue Market Share by Type (2021-2026) Table 28. Global Antimicrobial Peptides Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pharmaceuticals Table 30. Major Manufacturers of Feed Additives Table 31. Major Manufacturers of Others Table 32. Global Antimicrobial Peptides Sales by Application 2021 VS 2025 VS 2032 (Mg) Table 33. Global Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 34. Global Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 35. Global Antimicrobial Peptides Sales Market Share by Application (2021-2026) Table 36. Global Antimicrobial Peptides Sales Market Share by Application (2027-2032) Table 37. Global Antimicrobial Peptides Revenue by Application 2021 VS 2025 VS 2032 (Mg) Table 38. Global Antimicrobial Peptides Revenue by Application (2021-2026) & (Mg) Table 39. Global Antimicrobial Peptides Revenue by Application (2027-2032) & (Mg) Table 40. Global Antimicrobial Peptides Revenue Market Share by Application (2021-2026) Table 41. Global Antimicrobial Peptides Revenue Market Share by Application (2027-2032) Table 42. Global Antimicrobial Peptides Sales by Region: 2021 VS 2025 VS 2032 (Mg) Table 43. Global Antimicrobial Peptides Sales by Region (2021-2026) & (Mg) Table 44. Global Antimicrobial Peptides Sales Market Share by Region (2021-2026) Table 45. Global Antimicrobial Peptides Sales Forecasted by Region (2027-2032) & (Mg) Table 46. Global Antimicrobial Peptides Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Antimicrobial Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Mg) Table 48. North America Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 49. North America Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 50. Europe Antimicrobial Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Mg) Table 51. Europe Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 52. Europe Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 53. Asia Pacific Antimicrobial Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Mg) Table 54. Asia Pacific Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 55. Asia Pacific Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 56. South America, Middle East and Africa Antimicrobial Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Mg) Table 57. South America, Middle East and Africa Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 58. South America, Middle East and Africa Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 59. Global Antimicrobial Peptides Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Antimicrobial Peptides Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Antimicrobial Peptides Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Antimicrobial Peptides Revenue Market Share by Region (2021-2026) Table 63. Global Antimicrobial Peptides Revenue Market Share by Region (2027-2032) Table 64. AnaSpec Company Information Table 65. AnaSpec Business Overview Table 66. AnaSpec Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. AnaSpec Antimicrobial Peptides Product Portfolio Table 68. AnaSpec Recent Development Table 69. AMP Biotech Company Information Table 70. AMP Biotech Business Overview Table 71. AMP Biotech Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. AMP Biotech Antimicrobial Peptides Product Portfolio Table 73. AMP Biotech Recent Development Table 74. Phoenix Biotech Company Information Table 75. Phoenix Biotech Business Overview Table 76. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Phoenix Biotech Antimicrobial Peptides Product Portfolio Table 78. Phoenix Biotech Recent Development Table 79. Novabiotics Company Information Table 80. Novabiotics Business Overview Table 81. Novabiotics Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Novabiotics Antimicrobial Peptides Product Portfolio Table 83. Novabiotics Recent Development Table 84. Chinese Peptide Company Information Table 85. Chinese Peptide Business Overview Table 86. Chinese Peptide Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Chinese Peptide Antimicrobial Peptides Product Portfolio Table 88. Chinese Peptide Recent Development Table 89. Ontores Company Information Table 90. Ontores Business Overview Table 91. Ontores Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Ontores Antimicrobial Peptides Product Portfolio Table 93. Ontores Recent Development Table 94. GenScript Company Information Table 95. GenScript Business Overview Table 96. GenScript Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. GenScript Antimicrobial Peptides Product Portfolio Table 98. GenScript Recent Development Table 99. Hycult Biotech Company Information Table 100. Hycult Biotech Business Overview Table 101. Hycult Biotech Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hycult Biotech Antimicrobial Peptides Product Portfolio Table 103. Hycult Biotech Recent Development Table 104. Sunsmile Company Information Table 105. Sunsmile Business Overview Table 106. Sunsmile Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Sunsmile Antimicrobial Peptides Product Portfolio Table 108. Sunsmile Recent Development Table 109. Ruixing Biotechnology Company Information Table 110. Ruixing Biotechnology Business Overview Table 111. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Ruixing Biotechnology Antimicrobial Peptides Product Portfolio Table 113. Ruixing Biotechnology Recent Development Table 114. Zhongnong Yingtai Biotechnology Company Information Table 115. Zhongnong Yingtai Biotechnology Business Overview Table 116. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio Table 118. Zhongnong Yingtai Biotechnology Recent Development Table 119. Glam Technology Company Information Table 120. Glam Technology Business Overview Table 121. Glam Technology Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Glam Technology Antimicrobial Peptides Product Portfolio Table 123. Glam Technology Recent Development Table 124. ProteLight Pharmaceutical & Biotechnology Company Information Table 125. ProteLight Pharmaceutical & Biotechnology Business Overview Table 126. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Price (US$/Mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio Table 128. ProteLight Pharmaceutical & Biotechnology Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Antimicrobial Peptides Distributors List Table 132. Antimicrobial Peptides Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Antimicrobial Peptides Product Image Figure 2. Global Antimicrobial Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimicrobial Peptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Antimicrobial Peptides Sales (2021-2032) & (Mg) Figure 5. Global Antimicrobial Peptides Average Price (US$/Mg) & (2021-2032) Figure 6. Global Top 5 and 10 Antimicrobial Peptides Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plant Antimicrobial Peptides Image Figure 9. Microbial Antimicrobial Peptides Image Figure 10. Animal Antimicrobial Peptides Image Figure 11. Global Antimicrobial Peptides Sales by Type (2021 VS 2025 VS 2032) & (Mg) Figure 12. Global Antimicrobial Peptides Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Antimicrobial Peptides Sales Market Share by Type (2021-2032) Figure 14. Global Antimicrobial Peptides Revenue by Type (2021 VS 2025 VS 2032) & (Mg) Figure 15. Global Antimicrobial Peptides Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Antimicrobial Peptides Revenue Market Share by Type (2021-2032) Figure 17. Pharmaceuticals Image Figure 18. Feed Additives Image Figure 19. Others Image Figure 20. Global Antimicrobial Peptides Sales by Application (2021 VS 2025 VS 2032) & (Mg) Figure 21. Global Antimicrobial Peptides Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Antimicrobial Peptides Sales Market Share by Application (2021-2032) Figure 23. Global Antimicrobial Peptides Revenue by Application (2021 VS 2025 VS 2032) & (Mg) Figure 24. Global Antimicrobial Peptides Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Antimicrobial Peptides Revenue Market Share by Application (2021-2032) Figure 26. North America Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 27. North America Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 28. U.S. Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 29. Canada Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 30. Mexico Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 31. Europe Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 32. Europe Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 33. Germany Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 34. France Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 35. U.K. Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 36. Italy Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 37. Netherlands Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 38. Asia Pacific Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 39. Asia Pacific Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 40. China Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 41. Japan Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 42. South Korea Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 43. Southeast Asia Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 44. India Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 45. Australia Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 46. South America, Middle East and Africa Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 47. South America, Middle East and Africa Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 48. Brazil Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 49. South Africa Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 50. Saudi Arabia Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 51. Turkey Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 52. Argentina Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 53. UAE Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 54. Egypt Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 55. Chile Antimicrobial Peptides Sales and Growth Rate (2021-2032) & (Mg) Figure 56. Global Antimicrobial Peptides Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Antimicrobial Peptides Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Figure 59. North America Antimicrobial Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Figure 61. Europe Antimicrobial Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Antimicrobial Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Antimicrobial Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Antimicrobial Peptides Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Antimicrobial Peptides Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Antimicrobial Peptides
  • Microbial Antimicrobial Peptides
  • Animal Antimicrobial Peptides
Applications
  • Pharmaceuticals
  • Feed Additives
  • Others
Companies covered
  • AnaSpec
  • AMP Biotech
  • Phoenix Biotech
  • Novabiotics
  • Chinese Peptide
  • Ontores
  • GenScript
  • Hycult Biotech
  • Sunsmile
  • Ruixing Biotechnology
  • Zhongnong Yingtai Biotechnology
  • Glam Technology
  • ProteLight Pharmaceutical & Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antimicrobial Peptides Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antimicrobial Peptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antimicrobial Peptides Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antimicrobial Peptides Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antimicrobial Peptides Market Dynamics
  1. 2.1 Antimicrobial Peptides Industry Trends
  2. 2.2 Antimicrobial Peptides Industry Drivers
  3. 2.3 Antimicrobial Peptides Industry Opportunities and Challenges
  4. 2.4 Antimicrobial Peptides Industry Restraints
3 Antimicrobial Peptides Market by Manufacturers
  1. 3.1 Global Antimicrobial Peptides Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antimicrobial Peptides Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antimicrobial Peptides Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antimicrobial Peptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antimicrobial Peptides Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antimicrobial Peptides Manufacturers, Product Type & Application
  7. 3.7 Global Antimicrobial Peptides Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antimicrobial Peptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antimicrobial Peptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antimicrobial Peptides Tier 1, Tier 2, and Tier 3
4 Antimicrobial Peptides Market by Type
  1. 4.1 Antimicrobial Peptides Type Introduction
  2. 4.1.1 Plant Antimicrobial Peptides
  3. 4.1.2 Microbial Antimicrobial Peptides
  4. 4.1.3 Animal Antimicrobial Peptides
  5. 4.2 Global Antimicrobial Peptides Sales by Type
  6. 4.2.1 Global Antimicrobial Peptides Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antimicrobial Peptides Sales by Type (2021-2032)
  8. 4.2.3 Global Antimicrobial Peptides Sales Market Share by Type (2021-2032)
  9. 4.3 Global Antimicrobial Peptides Revenue by Type
  10. 4.3.1 Global Antimicrobial Peptides Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antimicrobial Peptides Revenue by Type (2021-2032)
  12. 4.3.3 Global Antimicrobial Peptides Revenue Market Share by Type (2021-2032)
5 Antimicrobial Peptides Market by Application
  1. 5.1 Antimicrobial Peptides Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Feed Additives
  4. 5.1.3 Others
  5. 5.2 Global Antimicrobial Peptides Sales by Application
  6. 5.2.1 Global Antimicrobial Peptides Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antimicrobial Peptides Sales by Application (2021-2032)
  8. 5.2.3 Global Antimicrobial Peptides Sales Market Share by Application (2021-2032)
  9. 5.3 Global Antimicrobial Peptides Revenue by Application
  10. 5.3.1 Global Antimicrobial Peptides Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antimicrobial Peptides Revenue by Application (2021-2032)
  12. 5.3.3 Global Antimicrobial Peptides Revenue Market Share by Application (2021-2032)
6 Global Antimicrobial Peptides Sales by Region
  1. 6.1 Global Antimicrobial Peptides Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antimicrobial Peptides Sales by Region (2021-2032)
  3. 6.2.1 Global Antimicrobial Peptides Sales by Region (2021-2026)
  4. 6.2.2 Global Antimicrobial Peptides Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antimicrobial Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antimicrobial Peptides Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antimicrobial Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antimicrobial Peptides Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antimicrobial Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antimicrobial Peptides Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antimicrobial Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antimicrobial Peptides Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antimicrobial Peptides Revenue by Region
  1. 7.1 Global Antimicrobial Peptides Revenue by Region
  2. 7.1.1 Global Antimicrobial Peptides Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antimicrobial Peptides Revenue by Region (2021-2026)
  4. 7.1.3 Global Antimicrobial Peptides Revenue by Region (2027-2032)
  5. 7.1.4 Global Antimicrobial Peptides Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antimicrobial Peptides Revenue (2021-2032)
  8. 7.2.2 North America Antimicrobial Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antimicrobial Peptides Revenue (2021-2032)
  11. 7.3.2 Europe Antimicrobial Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antimicrobial Peptides Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antimicrobial Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antimicrobial Peptides Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antimicrobial Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AnaSpec
  2. 8.1.1 AnaSpec Company Information
  3. 8.1.2 AnaSpec Business Overview
  4. 8.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AnaSpec Antimicrobial Peptides Product Portfolio
  6. 8.1.5 AnaSpec Recent Developments
  7. 8.2 AMP Biotech
  8. 8.2.1 AMP Biotech Company Information
  9. 8.2.2 AMP Biotech Business Overview
  10. 8.2.3 AMP Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AMP Biotech Antimicrobial Peptides Product Portfolio
  12. 8.2.5 AMP Biotech Recent Developments
  13. 8.3 Phoenix Biotech
  14. 8.3.1 Phoenix Biotech Company Information
  15. 8.3.2 Phoenix Biotech Business Overview
  16. 8.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Phoenix Biotech Antimicrobial Peptides Product Portfolio
  18. 8.3.5 Phoenix Biotech Recent Developments
  19. 8.4 Novabiotics
  20. 8.4.1 Novabiotics Company Information
  21. 8.4.2 Novabiotics Business Overview
  22. 8.4.3 Novabiotics Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novabiotics Antimicrobial Peptides Product Portfolio
  24. 8.4.5 Novabiotics Recent Developments
  25. 8.5 Chinese Peptide
  26. 8.5.1 Chinese Peptide Company Information
  27. 8.5.2 Chinese Peptide Business Overview
  28. 8.5.3 Chinese Peptide Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chinese Peptide Antimicrobial Peptides Product Portfolio
  30. 8.5.5 Chinese Peptide Recent Developments
  31. 8.6 Ontores
  32. 8.6.1 Ontores Company Information
  33. 8.6.2 Ontores Business Overview
  34. 8.6.3 Ontores Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ontores Antimicrobial Peptides Product Portfolio
  36. 8.6.5 Ontores Recent Developments
  37. 8.7 GenScript
  38. 8.7.1 GenScript Company Information
  39. 8.7.2 GenScript Business Overview
  40. 8.7.3 GenScript Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GenScript Antimicrobial Peptides Product Portfolio
  42. 8.7.5 GenScript Recent Developments
  43. 8.8 Hycult Biotech
  44. 8.8.1 Hycult Biotech Company Information
  45. 8.8.2 Hycult Biotech Business Overview
  46. 8.8.3 Hycult Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hycult Biotech Antimicrobial Peptides Product Portfolio
  48. 8.8.5 Hycult Biotech Recent Developments
  49. 8.9 Sunsmile
  50. 8.9.1 Sunsmile Company Information
  51. 8.9.2 Sunsmile Business Overview
  52. 8.9.3 Sunsmile Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sunsmile Antimicrobial Peptides Product Portfolio
  54. 8.9.5 Sunsmile Recent Developments
  55. 8.10 Ruixing Biotechnology
  56. 8.10.1 Ruixing Biotechnology Company Information
  57. 8.10.2 Ruixing Biotechnology Business Overview
  58. 8.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Portfolio
  60. 8.10.5 Ruixing Biotechnology Recent Developments
  61. 8.11 Zhongnong Yingtai Biotechnology
  62. 8.11.1 Zhongnong Yingtai Biotechnology Company Information
  63. 8.11.2 Zhongnong Yingtai Biotechnology Business Overview
  64. 8.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio
  66. 8.11.5 Zhongnong Yingtai Biotechnology Recent Developments
  67. 8.12 Glam Technology
  68. 8.12.1 Glam Technology Company Information
  69. 8.12.2 Glam Technology Business Overview
  70. 8.12.3 Glam Technology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Glam Technology Antimicrobial Peptides Product Portfolio
  72. 8.12.5 Glam Technology Recent Developments
  73. 8.13 ProteLight Pharmaceutical & Biotechnology
  74. 8.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
  75. 8.13.2 ProteLight Pharmaceutical & Biotechnology Business Overview
  76. 8.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio
  78. 8.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antimicrobial Peptides Value Chain Analysis
  2. 9.1.1 Antimicrobial Peptides Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antimicrobial Peptides Production Mode & Process
  6. 9.2 Antimicrobial Peptides Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antimicrobial Peptides Distributors
  9. 9.2.3 Antimicrobial Peptides Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst